C126H150N26O23S5 — CID 158018092
1-(1-cyclobutylpyrazol-3-yl)sulfonyl-3-[5-[2-(trideuteriomethoxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]urea;1-[5-[2-(1-methoxypropan-2-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(1-methylpiperidin-4-yl)oxy-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(oxan-3-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(oxolan-3-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea (PubChem CID 158018092) has the molecular formula C126H150N26O23S5 and a molecular weight of 2560.10 g/mol. Its IUPAC name is 1-(1-cyclobutylpyrazol-3-yl)sulfonyl-3-[5-[2-(trideuteriomethoxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]urea;1-[5-[2-(1-methoxypropan-2-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(1-methylpiperidin-4-yl)oxy-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(oxan-3-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(oxolan-3-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea.
| Compound Name | 1-(1-cyclobutylpyrazol-3-yl)sulfonyl-3-[5-[2-(trideuteriomethoxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]urea;1-[5-[2-(1-methoxypropan-2-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(1-methylpiperidin-4-yl)oxy-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(oxan-3-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(oxolan-3-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea |
|---|---|
| PubChem CID | 158018092 |
| Molecular Formula | C126H150N26O23S5 |
| Molecular Weight | 2560.10 g/mol |
| Exact Mass | 2558.02 |
| IUPAC Name | 1-(1-cyclobutylpyrazol-3-yl)sulfonyl-3-[5-[2-(trideuteriomethoxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]urea;1-[5-[2-(1-methoxypropan-2-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(1-methylpiperidin-4-yl)oxy-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(oxan-3-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea;1-[5-[2-(oxolan-3-yloxy)-4-pyridinyl]-2,3-dihydro-1H-inden-4-yl]-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea |
| SMILES | CC(C)n1ccc(S(=O)(=O)NC(=O)Nc2c(-c3ccnc(OC4CCCOC4)c3)ccc3c2CCC3)n1.CC(C)n1ccc(S(=O)(=O)NC(=O)Nc2c(-c3ccnc(OC4CCN(C)CC4)c3)ccc3c2CCC3)n1.CC(C)n1ccc(S(=O)(=O)NC(=O)Nc2c(-c3ccnc(OC4CCOC4)c3)ccc3c2CCC3)n1.COCC(C)Oc1cc(-c2ccc3c(c2NC(=O)NS(=O)(=O)c2ccn(C(C)C)n2)CCC3)ccn1.[2H]C([2H])([2H])Oc1cc(-c2ccc3c(c2NC(=O)NS(=O)(=O)c2ccn(C4CCC4)n2)CCC3)ccn1 |
| InChI | InChI=1S/C27H34N6O4S.C26H31N5O5S.C25H29N5O5S.C25H31N5O5S.C23H25N5O4S/c1-18(2)33-16-12-25(30-33)38(35,36)31-27(34)29-26-22-6-4-5-19(22)7-8-23(26)20-9-13-28-24(17-20)37-21-10-14-32(3)15-11-21;1-17(2)31-13-11-24(29-31)37(33,34)30-26(32)28-25-21-7-3-5-18(21)8-9-22(25)19-10-12-27-23(15-19)36-20-6-4-14-35-16-20;1-16(2)30-12-9-23(28-30)36(32,33)29-25(31)27-24-20-5-3-4-17(20)6-7-21(24)18-8-11-26-22(14-18)35-19-10-13-34-15-19;1-16(2)30-13-11-23(28-30)36(32,33)29-25(31)27-24-20-7-5-6-18(20)8-9-21(24)19-10-12-26-22(14-19)35-17(3)15-34-4;1-32-20-14-16(10-12-24-20)19-9-8-15-4-2-7-18(15)22(19)25-23(29)27-33(30,31)21-11-13-28(26-21)17-5-3-6-17/h7-9,12-13,16-18,21H,4-6,10-11,14-15H2,1-3H3,(H2,29,31,34);8-13,15,17,20H,3-7,14,16H2,1-2H3,(H2,28,30,32);6-9,11-12,14,16,19H,3-5,10,13,15H2,1-2H3,(H2,27,29,31);8-14,16-17H,5-7,15H2,1-4H3,(H2,27,29,31);8-14,17H,2-7H2,1H3,(H2,25,27,29)/i;;;;1D3 |
| InChIKey | FFSLMEAQEPHZNV-SKUNORNJSA-N |
| XLogP | 19.39 |
| TPSA | 606.98 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 39 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 180 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2560.10 |
| LogP ≤ 5 | 19.39 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 39 |